Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr 21;1(4):263-4.
doi: 10.1021/cn100022a.

ACS chemical neuroscience molecule spotlight on Saphris

Corey R Hopkins  1
Affiliations

ACS chemical neuroscience molecule spotlight on Saphris

Corey R Hopkins. ACS Chem Neurosci. .

Erratum in

  • ACS Chem Neurosci. 2010 Jun 10;1(7):529

Abstract

On August 14th, 2009, for the first time, the FDA has approved a psychotropic medication for two indications simultaneously. Saphris (asenapine) is a multitarget atypical antipsychotic medication approved to treat adults with schizophrenia and bipolar I disorder.

PubMed Disclaimer

References

    1. FDA New Release, August 14, 2009. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm177401.htm
    1. Day R.; Nielsen J. A.; Korten A.; Ernberg G.; Dube K. C.; Gebhart J.; Jablensky A.; Leon C.; Marsella A.; Olatawura M.; Sartorius N.; Strömgren E.; Takahashi R.; Wig N.; Wynne L. C. (1987) Stressful life events preceding the acute onset of schizophrenia: A cross-national study from the World Health Organization. Cult., Med., Psychiatry 11, 123–205. - PubMed
    1. www.schizophrenia.com/szfacts.htm
    1. http://www.nimh.nih.gov/health/publications/the-numbers-count-mental-dis...
    1. Shahid M.; Walker G. B.; Zorn S. H.; Wong E. (2009) Asenapine: A novel psychopharmacolgic agent with a unique human receptor signature. J. Psychopharmacol. 23, 65–73. - PubMed

MeSH terms